We combine visionary thinking and compassionate care with the science of treating cancer. An NCI-designated Comprehensive Cancer Center, part of @NYULangone
New York, NY
- Tweets 2,395
- Following 467
- Followers 1,607
- Likes 2,561
Congratulations to @DrBenNeel, director of our cancer center, who was just elected to the @theNASciences in recognition of distinguished and continuing achievements in original research. High honor for a scientist!
Read more: bit.ly/3KFE3Rf
7
13
164
Congrats to Associate Professor of Biochemistry and Molecular Pharmacology, Dr. Karim Jean- Armache @KJArmache who is a recipient of the 2022 emerging leaders award by the @TheMarkFdn for his work in addressing unmet needs in cancer research. bit.ly/3quBieQ
8
11
78
Congrats to radiation oncologist Dr. Michael Pacold @MichaelPacold who is a recipient of the @DamonRunyon innovative award for his work in accelerating cancer research.
Learn more: bit.ly/3qsiqwL
10
2
82
Congrats to our @DrBenNeel for being elected to the @theNASciences this year; and Drs. Dafna Bar-Sagi and @KathrynMooreLab for their inductions to NAS the past 2 yrs. @nyulangone
Read more: bit.ly/3PaoYum
8
44
Our @theLundLab reported in @NatImmunol that plugging immune cell leakage from tumors could improve skin cancer treatment
bit.ly/3xZOkDU
8
39
4,916
We're proud to share that our Dr. Eva Hernando-Monge is one of several recipients of the Translational Research Award through @thevfoundation’s "Grant of Her Own" program for her work in melanoma brain metastasis!
For more about the award: prn.to/3pu8bu7
3
5
42
3,625
Congrats to radiation oncologist Dr. Alec Kimmelman for being inducted to the Association of American Physicians (AAP). This is an honor extended to select doctors in biomedical research. @NYULH_RadOnc @nyulangone
🔗 bit.ly/3xCJwFJ
4
44
Congrats to @theLundLab, on the 2022 @AACR @bmsnews Female Investigator Grant: Targeting lymphatic transport to boost immune memory & reduce recurrence.
@AACR believes this project will have great impact, & recognizes her as a future leader in the field. bit.ly/37LgSam
5
32
Congratulations to our #myeloma expert, Dr. Faith Davies (@FaithEDavies1), a patient-nominated 2023 Women of Distinction being honored by @SeawrightForNY! @theMMRF
Learn more about Dr. Davies: bit.ly/3LXr4Nm
4
3
33
2,019
Elevated prostate-specific antigen (PSA) scores can help detect early-stage #prostatecancer. This metric helped @FoxNews correspondent @CGasparino beat his cancer early.
Charlie thanks our care team in this @FoxNewsOpinion story ⤵️
fxn.ws/3NuFOpo
1
4
29
4,766
Her breast cancer misdiagnosed at age 29, @AmericanCancer's LaToya Williams came to @nyulangone's Perlmutter Cancer Center to rebuild trust & is now 15 yrs. cancer free. “The care I get at NYU spoiled me to never accept less. I feel seen and heard.” @CancerNYNJ @FinanceVSCancer
9
26
Our cancer researcher Dr. Amanda Lund (@theLundLab) seeks to understand mechanisms of cancer metastasis. Learn more about Dr. Lund's research and how it benefits people with cancer. @TheMarkFdn @CancerResearch @nyulangone
🔗 bit.ly/39SkmsC
8
26
Congratulations to our fearless director @DrBenNeel, an Academy of Science Fellow of the Royal Society of Canada! @RSCTheAcademies
The 2023 fellows will be inducted and celebrated at the #COEE2023 #RSC annual meeting on November 17!
Learn more: rsc-src.ca/
5
4
25
1,683
Congrats to medical oncologist Dr. Janice Mehnert, @JaniceM10 for her appointment as the new co-chair of the @eaonc #melanoma committee.
Learn more: bit.ly/3p8Zous
3
6
27
Congratulations to our @DrBenNeel for his #NASmember induction to @theNASciences this weekend! #NAS160
Learn more about Dr. Neel's work: bit.ly/41Y7GGP
2
23
3,750
We’re pleased to welcome former @NYUGSOM_HemeOnc fellow & @ASCO award recipient, Dr. Minas P. Economides (@minaseconomides), to Perlmutter Cancer Center's Genitourinary Oncology—Manhattan team!
Learn about his expertise & research: bit.ly/3FrzIRB
3
4
27
1,211
Congratulations to Jun Wang, PhD (@jwang133) and Iannis Aifantis, PhD (@iannisaifantis1), recipients of the @TheMarkFdn’s ASPIRE award for their trailblazing exploration of antigen presentation inhibitors in cancer immunotherapeutics.
Learn more: bit.ly/3t3zAoR
2
5
24
9,964
Congratulations to our urologic oncology fellow Dr. Minas Economides (@minaseconomides), an #ASCO23 Young Investigator Award recipient, for his work to advance the treatment of bladder cancer! @ConquerCancerFd @NYUGSOM_HemeOnc
Check out his team's work: bit.ly/42kscAQ
8
27
2,757
"Kudos to @PanCAN for their work in looking for a link between #diabetes & #pancreaticcancer in this @nytimes piece (sub. required). A larger focus on early detection & understanding risk factors of #pancreaticcancer is also needed," says @MadameSurgeon nyti.ms/34v8eLS
1
9
25
Congratulations to Perlmutter Cancer Center's @MichaelPacold! 👏🌟
We are thrilled to announce the seven innovative early-career cancer researchers in NY and CT who are the Pershing Square Sohn Cancer Research Alliance’s 2022 Prize winners! Stay tuned for a little more about each of them throughout the day. #PSSCRA22 psscra.org/2022/06/07/press-…
2
2
24
Kudos to Dr. Alec Kimmelman on a $1.7 million Drug Discovery Award from @TheMarkFdn. He & Dr. Seth Parker @UBC will work to ID molecules that inhibit the amino acid transporter SLC38A2, a novel target for #pancreaticcancer @nyugrossman @NYULH_RadOnc
bit.ly/3jELZL9
8
23
2,806
An academic platform for scientists, @guide2research, published their Top 1,000 Scientists in genetics & molecular biology.
Congrats to @nyulangone's top scientists in the US including: @ReinbergDanny (#47), @DrBenNeel (#239) & @NovickRichard (#292).
🔗 bit.ly/3xt6VsM
6
18
Congratulations to our Dr. Joseph Ravenell, recipient of the @AmericanCancer Eugene O'Kelly Award at this year's 15th annual Financial Services Cares Gala at Cipriani 25 Broadway. @pophealthNYC @nyugrossman
3
19
We are proud to be part of the #3 hospital in the U.S. and ranked among the Top 20 for cancer.
Learn more about our top-ranked care here: bit.ly/3J68ReF
10
18
Gene expression in tumor-adjacent tissue holds significant prognostic information in lung adenocarcinoma, research from @NYUGSOM_PMED finds.
Learn about the findings from investigators Dr. Igor Dolgalev (@bioigor) and Dr. Aristotelis Tsirigos (@artsinyc): bit.ly/49BZy2R
6
21
4,980
Congratulations to @EmelineAvikiMD, of Perlmutter Cancer Center at @NYULangoneLI, who will serve on the 2024-2025 board of directors for The Society of Gynecologic Oncology (@SGO_Org)! #gyncsm
Learn about the SGO’s vision: bit.ly/41TuIiJ
4
20
5,506
A study led by @DrBenNeel & Dr. Shohei Koide shows that an antibody helps kill cancer cells resistant to the KRAS inhibitor sotorasib.
The study suggests a new way to use immunotherapy to treat tumors with the KRAS-G12C mutation. ⤵️
bit.ly/3GImEc7
1
4
20
Congratulations to our Dr. Abraham Chachoua, recognized by @nyulangone Dean and CEO Dr. Robert I. Grossman and the family of Robert Antonio Magliocco, Jr., with a named professorship at @nyugrossman's Dean's Honors Day!
Learn about his accomplishments: bit.ly/473MWj9
4
21
1,469
Congratulations to six Perlmutter Cancer Center/@NYUGrossman scientists who have been named "Top Cited Researchers" by @Clarivate for publishing influential papers that rank in the top 1% of citations in their field in the past decade!
Learn more: bit.ly/3Nz07kB
3
17
1,106
Studies led by researchers at @nyulangone reveal how melanoma metastasizes in the brain & how epigenetic regulation may aid its spread. Pathologist Dr. Eva Hernando-Monge comments on the two studies published in @CD_AACR. @ScienceMagazine
Read more: ⤵️
bit.ly/3dKvom2
7
19
This June, middle school students from @SunsetParkPrep joined our cancer biologists from @nyulangone for a mobile @BioBus visit to investigate the world through a different lens and experience the joy of scientific discovery! 🔬
1
4
19
1,591
Tonight’s @CBS Evening News will broadcast a breast cancer disparities segment shot at Perlmutter Cancer Center and features breast cancer surgeon @Kathie_JosephMD, patient LaToya Williams & others. It will highlight what needs to be done to reduce barriers for women of color.
1
9
16
@MaurerFdn is celebrating trailblazing women in medicine! They honored one of our doctors: “@AbreoNina stands out for her intellect, patient-centric care, advancements for breast cancer patients & being a female leader in medicine.” @NYULangoneLI
🔗bit.ly/3uiOsvO
7
2
18
It’s our pleasure to welcome gynecological oncologist Dr. Emeline Aviki (@EmelineAvikiMD) to our Perlmutter Cancer Center team!
Dr. Aviki will treat patients with #gyncsm cancers at our Mineola & Patchogue @NYULangoneLI locations.
Learn more: bit.ly/45alH5X
1
18
6,301
More moments from the @AmericanCancer Financial Services Cares Gala celebrating our Dr. Joseph Ravenell and his amazing work in addressing health disparities affecting communities of color. Congrats! 👏 @pophealthNYC @FinanceVSCancer @nyulangone
📷: @ericvitalephoto
4
16
Happy to celebrate Dr. Joseph Ravenell, (w/ wife, left) recipient of the @AmericanCancer Eugene O'Kelly Award at the Financial Services Cares Gala for work in addressing health disparities. On right is PCC doc @JaniceM10 #financeVScancer
@pophealthNYC @FinanceVSCancer
6
17
We have many women who lead in cancer advances. JiYoung Ahn leads an @theNCI funded SPORE grant to better understand orodigestive tract health disparities to create personalized prevention & intervention. #WomensHistoryMonth @pophealthNYC @nyugrossman
🔗bit.ly/3I8gqiU
7
18
NYU Grossman School of Medicine has been ranked number 2 in the nation out of 192 schools as a best medical school for research, on @usnews 2022–23 list of “Best Graduate Schools.” We are proud to be a partner with @nyugrossman @nyulangone.
🔗bit.ly/3DiF67C
4
16
Our Dr. Paul Oberstein (@md_oberstein) is one of several pancreatic cancer doctors who see this as an exciting new treatment. But it will take some time to get this to work with a bigger number of patients. @TopStoryNBC @LlamasNBC
An experimental treatment appears to have been successful in halting the progression of one woman’s advanced pancreatic cancer.
Researchers think it has the potential to benefit millions more people.
Dr. Paul Oberstein joins @LlamasNBC to discuss the breakthrough treatment.
7
18
Patients can wait weeks for tumor pathology results to diagnose #braincancer. But now, new technology from neurosurgeon @DanOrringerMD demonstrates how AI can reduce that time to just three minutes.
Watch the @NBCNewsNow segment with @DrAkshaySyal 🔽 nbcnews.to/44rtwUU
7
14
1,785
On National Doctor’s Day, Perlmutter Cancer Center would like to say thanks to our physicians for the incredible work they do treating cancer patients! #NationalDoctorsDay
1
4
16
Medical oncologist @ElaineShumMD has opened a phase 1/2 study of the highly selective EGFR inhibitor BLU-701 in patients with EGFR-Mutant non-small cell lung cancer. #clinicaltrialsday2022
Learn more: bit.ly/3lr88dd
4
16
Dr. Eva Hernando-Monge led a study in @CD_AACR that revealed a new connection between melanoma brain metastasis and neurodegeneration. Funding by @AmericanCancer and @MelanomaReAlli #melanoma #skincancer
Learn more: bit.ly/3w5Ay2F
6
17
Congratulations to our melanoma surgeon, Dr. Russell Berman @bermar01, who has been appointed Vice President of @SocSurgOnc 👏
Proud to share our Program Director, Dr. Russell Berman @bermar01, has been appointed @SocSurgOnc Vice President. Congratulations on a well deserved new role, we are thrilled for you! 🎊 #SSO #NYULangone
3
16
Congratulations to medical oncology fellows Dr. Peter Yu and Dr. Chengwei Peng, who received @ASCO Young Investigator Awards, providing funding to promising investigators to encourage and promote quality research in clinical oncology.
1
1
14
As the new director of breast cancer clinical research, medical oncologist Dr. Nancy Chan is helping us advance #clinicaltrials for #breastcancer patients. Learn more: bit.ly/3JwZOT6
2
3
15
In partnership with @TheMarkFdn, our @NYUGSOM_Path investigators have identified a trimolecular complex that may yield new strategies to improve checkpoint inhibitor efficacy in AML.
Learn more from co-authors @iannisaifantis1, @jwang133 & @Xufeng_Chen: bit.ly/3NxrbAI
3
14
3,627
"Neoantigen strategies are the most promising vaccine strategies in oncology today," says Perlmutter Cancer Center deputy director Dr. Jeffrey Weber. @AACR
Check out the discussion on the latest advancements in therapeutic cancer vaccines from #AACR23: bit.ly/3qCMUP3
3
14
1,214
Our medical oncologist @JSabari: “Activity of Adagrasib (MRTX849) in Brain Metastases: Preclinical Models & Clinical Data From Patients w/ KRASG12C-Mutant Non-Small Cell Lung Cancer” @AACR @CCR_AACR
bit.ly/3O5CEq8
1
4
15
Our Amanda Lund (@theLundLab) is giving a major symposium talk at the upcoming #AACR2023: Tumor-associated lymphatic vessels and T cell transit through the tumor microenvironment. She’s @CancerResearch funded scientist @AACR
Read more: bit.ly/3o3oexT
2
13
8,160
Today is #WorldCancerDay. @Perlmutter_CC at @nyulangone is doing its part to reduce cancer disparities in our part of the world through a major health initiative called Stamp Out Cancer Brooklyn. #CloseTheCareGap
Learn more: bit.ly/3urdmes
10
14
In a @Medcape series, a multidisciplinary team from @nyulangone discusses their collaborative efforts to optimize treatment in #NSCLC.
🎥 Check out episode 5 on adjuvant therapy, featuring our Drs. @ElaineShumMD, @StermanDaniel, and Abraham Chachoua: wb.md/3vB01TJ
7
13
1,529
Under the care of our Drs. Sylvia Adams and Richard Shapiro, fashion model #LindaEvangelista was treated at Perlmutter Cancer Center for breast cancer.
Linda—we admire your vulnerability and bravery in sharing your story in @AppleTV's #TheSuperModels: apple.co/45X3WHy
1
3
12
1,360
Congratulations to hem/onc fellow Dr. Minas Economides @minaseconomides who has been selected as chief oncology fellow for 2022-2023.
3
14
Study looks at early-stage pancreatic cancer detection. Dr. Diane Simeone @madamsurgeon said exploring new technologies to detect cancers sooner in high-risk patients is critical to improving patient outcomes @nyulangone @nyugrossman
bwnews.pr/3wJWSy8
2
2
15
1,130
In review of #IMS23, our @DrGarethMorgan1 highlights how novel advances in #multiplemyeloma are transforming—and progressing—research and clinical care in the field.
Watch here on @VJHemOnc: bit.ly/46sdvOG
5
15
1,175
NYU Langone Health Opens 5-Story Multispecialty Care Center in Brooklyn's Cobble Hill; Cancer Center Treatment, Infusion Available as Well
➡️bit.ly/410QIqA
5
15
6,431
How can we reduce anxiety in patients undergoing #radiationtherapy? Our Dr. David Byun’s CurieUX, an immersive #AI patient education tool, is a promising step in right direction.
His team’s work @NYULH_RadOnc is featured on @ASTRO_ORG for #NCRM23 here: bit.ly/44s0zIh
3
14
2,469
Congratulations to Dr. John Allendorf, @Perlmutter_CC leader & @nyulisom surgical oncology chief, who has been named the next chair of the department of surgery at @NYULangoneLI.
More on Dr. Allendorf: bit.ly/3U2VR19
1
2
13
2,265
Congrats to program manager Amin Yakubov, on being awarded the best programmatic or research staff research poster at the Annual @NYULangoneHealth Disparities Symposium for his poster, “Pre-Screening As a Tool for Increasing Oncology Trial Enrollment.” bit.ly/3JqQEaT
1
3
13
New report from the Global Society of Rare Genitourinary Tumors (@GTumors): “Safety and Efficacy of Immune Checkpoint Inhibitors in Advanced Penile Cancer,” co-authored by @ScotNiglio of @NYUUrology. #GUPATH #GUCancers
Read it in @JNCI_NOW: bit.ly/3qisiw4
10
13
2,043
Immunotherapies ‘offer incredible hope’ in journey toward #multiplemyeloma cure. “Some responses are lasting anywhere between 1 to 3 years, which is quite unusual in the relapsed and refractory setting,” our Dr. @FaithEDavies1 notes @healio @nyugrossman
bit.ly/3nTy4Tb
6
13
1,158
The multidisciplinary team at our Center for Blood Cancers Research collaborates so that discoveries in the lab lead to improved treatments for #bloodcancer patients. @FaithEDavies1 @DrGarethMorgan1 @docbraunstein @iannisaifantis1
Learn more: bit.ly/3K0XuGs
4
12
3,057
Medical oncologist Dr. Janice Mehnert @JaniceM10 has opened a trial for patients with advanced malignancies. Learn more about this Phase I study evaluating the drug REGN3767 alone or in combination with REGN2810. #clinicaltrials bit.ly/3quUmZ7
4
13
The @US_FDA approved ciltacabtagene autoleucel (Carvykti) for people with multiple myeloma. @FaithEDavies1 speaks to the @theNCI's Cancer Currents Blog on the importance of having another therapeutic approach in our toolbox.
🔗 bit.ly/3rBrnUL
5
12
Perlmutter Cancer Center is excited to welcome Dr. Michael Zelefsky, a a renowned leader in radiation oncology who will enhance our position as a leader in #prostatecancer with our @NYULH_RadOnc and @NYUUrology teams!
Learn about his expertise: bit.ly/45374k9
2
5
12
1,341
A study in @Nature led by @Perlmutter_CC researchers revealed that the amino acid valine plays a role in cancerous growth in T-cell acute lymphoblastic leukemia. Experiments showed that dietary valine deficiency can stall this cancer’s progression. bit.ly/32Nak8N
4
10
A study by @nyulangone researchers analyzed catheter-based therapies (CBTs) in cancer patients with intermediate/high-risk pulmonary embolism (PE).
In an interview with @cardiacinterv, study authors @SripalBangalore and @LeivaOrly discuss key findings ⤵️ bit.ly/3vD7L7J
5
12
1,596
On May 17, medical oncologist @JSabari will speak on the current standard of care for non-small lung cancer in the context of #COVID19, as well as the caregiver’s role in decision-making for a loved one with cancer. @CancerCare
Register: bit.ly/3kXqYbv
2
13
@Perlmutter_CC congratulates Dr. Robert Banh, Assistant Professor of Biochemistry and Molecular Pharmacology at @nyugrossman for being a recipient of the @DamonRunyon award for breakthrough scientists.
Learn more: bit.ly/3GnPjj6
3
13
A world-renowned expert in brachytherapy and treating genitourinary cancers, our Dr. Michael Zelefsky of @NYULH_RadOnc shares his vision in personalizing treatments, advancing radiation therapies, and expanding research in the field in a new Q&A: bit.ly/3LvlP87
6
13
1,110
How is the genomic landscape of multiple myeloma changing?
At the 2023 @COMyCongress meeting, multiple myeloma specialist Dr. J. Gareth Morgan shares how the disease's mutational signatures has advanced research in the field with @VJHemOnc.
Watch here: bit.ly/3CUaUAl
5
13
1,327
A $38.7 million @NIH grant will launch a new epidemiological study from @FredHutch on underrepresented Asian American, Native Hawaiian, and Pacific Islander health.
PIs will include our Dr. Jiyoung Ahn and Dr. Yu Chen @PophealthNYC! For more: bit.ly/3ZdUD3k
1
5
12
1,543
Pathologist Dr. Matija Snuderl speaks with @Inside_PM on the role of DNA Methylation in #Neuropathology and new technologies in #epigenetics being adopted at to drive this field forward.
Listen here: bit.ly/3sEeclG
2
12
Congratulations genitourinary oncology chief fellow Dr. Minas Economides of @NYUGSOM_HemeOnc @nyugrossman! #ASCO23 @ASCO
4
10
1,524
Our @NYUGSOM_Path investigators have identified a trimolecular complex that may yield new strategies to improve checkpoint inhibitor efficacy in AML & other solid cancers.
Learn more with co-authors @Iannisaifantis, @jwang133, @Xufeng_Chen & Dr. Qiao Lu: bit.ly/3NxrbAI
1
4
12
1,790
Our Dr. Jeffrey Weber spoke with the @WSJ about the promising melanoma research he presented at #AACR23 today. An #mRNA shot & pembro helped prevent relapse in hi-risk patients @moderna_tx @Merck
wsj.com/articles/moderna-sho…
5
10
939
We have many women who lead in cancer advances. @drosmannyu is a melanoma researcher who has been central to an @NCI-funded grant to develop tools to predict melanoma immunotherapy treatment outcomes. @NYUGSOMimcg #WomensHistoryMonth
🔗bit.ly/3D5zXzG
5
12
With a focus on discovering new and effective immunotherapies for esophageal cancer, a new Stand Up to Cancer (@SUC2) project will be co-led by our Dr. Kwok-Kin Wong and Dr. Anil K. Rustgi of @columbiacancer.
Learn more: bit.ly/442ie8l
4
10
1,130
On 9/23, @nyugrossman is offering an accredited course on the pathophysiology, diagnosis, & treatment of pancreatic diseases including pancreatitis, high-risk & pre-cancerous conditions, & pancreatic cancer.
Register to hear our cancer/surgery experts:
bit.ly/3RONT7v
3
10
Scientists at the New York Genome Center @nygenome, @nyugrossman, @Perlmutter_CC developed a platform to identify genes that enhance immune cells-making them more persistent, w/ increased ability to eradicate tumor cells. @ScienceDaily @Nature
🔗bit.ly/3IifJDS
4
11
We're excited to announce new leadership for our Clinical Trials Office: medical director @BPothuri & Phase 1 director @kspencer725. Additionally, we've joined a national clinical trials network, expanding access to early stage clinical trials.
🔗 bit.ly/3aTTucz
2
11
More than 114,800 women will receive a #gynecologiccancer diagnosis this year, @AmericanCancer estimates.
Join us for a comprehensive #womenshealth webinar on 9/18 at 6 pm ft. #gynsm oncologists from @NYULangone, @NYULangoneLI & @NYULangoneBK.
Register: bit.ly/3qPbWel
2
9
605
Medical oncologist Dr. Jeffrey Weber opened a trial to evaluate the efficacy & safety of a new drug combination compared with nivolumab after complete resection of #melanoma in patients at high risk of recurrence. Learn more: bit.ly/3Jz1ICD
4
10
This is how you make raising money for cancer research fun! Staff at @nyulangone's Perlmutter Cancer Center-Long Island held a “Making Strides Against Breast Cancer Boot Camp” & asked people to donate. Thanks to team captain @amandamarie7161 for organizing! @AmericanCancer.
4
11
“We’re proud to partner with the @AmericanCancer to raise awareness about breast cancer,” says Dr. Sylvia Adams, director of our breast cancer center, pictured here with fellow PCC breast cancer researcher, Dr. Theresa Vincent.
1
2
11
Medical oncologist Dr. Jeffrey Weber opened a trial for patients with unresectable stage III or stage IV #melanoma. This study tests the safety, tolerability, & effectiveness of the drug tocilizumab when given with the drugs ipilimumab & nivolumab. bit.ly/3JcWo7Q
5
10
Daughters of a breast cancer survivor, Maya and Chandni raised money to make homemade care packages for our patients at Perlmutter Cancer Center—Mineola.
Thank you for inspiring positivity, joy, and hope in many—both inside and outside the infusion center 💜
3
9
1,915
Expand your knowledge of novel treatment approaches in #NSCLC by joining our experts on 12/14 for #OncLiveSOSS—Lung Cancer.
Speakers include Drs. @VamsiVelcheti, Sally Lau, @ElaineShumMD, @JSabari,
@salmanpunekar & Abraham Chachoua.
Register: bit.ly/3Mu8woX | @OncLive
1
4
10
754
Join @Perlmutter_CC’s Dr. Deanna Gerber on @NYUDocs this Wednesday March 15 (8-9 a.m. ET) to discuss critical advances in gynecological cancers, including ovarian, cervical & endometrial. @SiriusXM (Ch. 110). All part of #Women'sHealthMonth @nyulangone
1
9
471
Drug shortages are not new — but how are recent chemotherapy drug shortages affecting clinicians and patients?
In an interview with @TargetedOnc, Dr. Joshua Sabari (@JSabari) discusses what oncologists are doing to help address this problem: bit.ly/3ClERsO
3
8
1,401
In response to the annual @AACR report, cancer experts, like @VamsiVelcheti, draw attention to how record drug shortages continue to affect clinicians, researchers and—most importantly—patients.
▶️ Read more on @CNN:bit.ly/486dZvo
2
10
841
Our Tory Foster and Anita McFarlane at the @BK_Marathon raising funds for Stamp Out Cancer Brooklyn, an initiative that aims to reduce the overall burden of cancer and alleviate cancer-related disparities in Brooklyn. @pophealthNYC.
Learn more: bit.ly/3rPswrV
4
9
.@NCICRCHD-hosted programs enable Dr. Jiyoung Ahn of @pophealthNYC to evaluate the complex factors perpetuating disparities in cancer incidence and mortality rates among racial, ethnic, and underserved populations.
Watch to hear more about Dr. Ahn's work ⤵️
3
9
1,201
Congratulations to Dr. Joseph Ravenell, who is among @cancerhealthmag's 25 recipients of remarkable individuals who are helping people affected by cancer live their best lives. @pophealthNYC
bit.ly/3nueY2E
3
9
Our medical oncologist @VamsiVelcheti uses cancer biomarkers to care for people with non-small cell lung cancer. Read more about Dr. Velcheti's work and how biomarkers make a dramatic difference in those with late-stage disease.
🔗 bit.ly/38EuCol
1
9
Perlmutter Cancer Center is among four NYC cancer centers to receive a $1 million grant from Stamp Out To Cancer (@SU2C) to improve lung cancer care for underserved minorities by providing technology-enabled monitoring of immunotherapy side effects.
🔗 bit.ly/3u7p6lk
5
9
Congratulations to PCC member @bermar01! 🌟
Our very own PD, Dr. Russell Berman, MD @bermar01, professor and vice chair for education & faculty affairs within the Dept of Surgery, was the recipient of the 2021 GME Program Director of the Year Award from the Educator Community at NYU Grossman School of Medicine @nyugrossman
1
10